Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Acta Biológica Colombiana
versão impressa ISSN 0120-548X
Resumo
BLANCO LEZCANO, LISETTE et al. Modify Beam Transversal Test to Evauate Hemiparkinsonian Rats. Acta biol.Colomb. [online]. 2010, vol.15, n.2, pp.189-202. ISSN 0120-548X.
The nigrostriatal degeneration underlying Parkinsons disease (PD) is commonly studied in experimental animals by injection of the neurotoxin 6-hydroxydopamine. The present study describes a modified version of a beam traversal test which allows the quantification of the motor deficit through the time spent to arrive to the platform once all four paws of the animals are in contact with the beam (escape latency, EL), the time spent before falling (tumbled down latency, TDL) and the number of errors (NE) committed for the animals in each beam. The shape and the diameter of the cross section of the beams were modified from rectangular and circular cross section with 2,5 cm of diameter to the same shape with 1 cm of diameter, which induced a high difficulty to the execution of the test. Three groups of Wistar rats were examined: untreated (n=15), lesioned with 6-hydroxydopamine (n=14), and sham-operated (n=14). All variables studied showed significant differences between control and hemiparkinsonian rats. The EL and the NE were increased and the TDL was decreased in hemiparkinsonian rats for all beams in comparison with control rats. In TDL the significant differences between groups were more evident (p<0.001) for the beams with high cross section irrespective of the shape of the cross section. BTT is a convenient sensorimotor test that does not need to be trained extensively, and require adverse motivation or food deprivation and appears to be very useful in evaluating the motor deficits in established unilateral model of PD and also other experimental models.
Palavras-chave : 6-hydroxydopamine; beam traversal test; dopamine; Parkinsons disease.